IART
Price
$13.57
Change
+$0.23 (+1.72%)
Updated
Oct 13, 03:46 PM (EDT)
Capitalization
1.04B
16 days until earnings call
RVP
Price
$0.97
Change
-$0.00 (-0.00%)
Updated
Oct 13, 04:59 PM (EDT)
Capitalization
29.18M
Interact to see
Advertisement

IART vs RVP

Header iconIART vs RVP Comparison
Open Charts IART vs RVPBanner chart's image
Integra LifeSciences Holdings
Price$13.57
Change+$0.23 (+1.72%)
Volume$400
Capitalization1.04B
Retractable Technologies
Price$0.97
Change-$0.00 (-0.00%)
Volume$1.46K
Capitalization29.18M
IART vs RVP Comparison Chart in %
IART
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IART vs. RVP commentary
Oct 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IART is a Buy and RVP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 13, 2025
Stock price -- (IART: $13.34 vs. RVP: $0.97)
Brand notoriety: IART and RVP are both not notable
IART represents the Medical/Nursing Services, while RVP is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: IART: 71% vs. RVP: 134%
Market capitalization -- IART: $1.04B vs. RVP: $29.18M
IART [@Medical/Nursing Services] is valued at $1.04B. RVP’s [@Pharmaceuticals: Other] market capitalization is $29.18M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $230.73B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $154B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.56B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IART’s FA Score shows that 1 FA rating(s) are green whileRVP’s FA Score has 1 green FA rating(s).

  • IART’s FA Score: 1 green, 4 red.
  • RVP’s FA Score: 1 green, 4 red.
According to our system of comparison, RVP is a better buy in the long-term than IART.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IART’s TA Score shows that 4 TA indicator(s) are bullish while RVP’s TA Score has 4 bullish TA indicator(s).

  • IART’s TA Score: 4 bullish, 6 bearish.
  • RVP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RVP is a better buy in the short-term than IART.

Price Growth

IART (@Medical/Nursing Services) experienced а -9.86% price change this week, while RVP (@Pharmaceuticals: Other) price change was +12.68% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.02%. For the same industry, the average monthly price growth was +2.38%, and the average quarterly price growth was +22.17%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -3.19%. For the same industry, the average monthly price growth was -2.07%, and the average quarterly price growth was +15.68%.

Reported Earning Dates

IART is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Medical/Nursing Services (-0.02% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-3.19% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IART($1.04B) has a higher market cap than RVP($29.2M). RVP YTD gains are higher at: 41.589 vs. IART (-41.182). RVP has higher annual earnings (EBITDA): -829.43K vs. IART (-332.17M). IART has more cash in the bank: 254M vs. RVP (33.1M). RVP has less debt than IART: RVP (1.07M) vs IART (2.01B). IART has higher revenues than RVP: IART (1.62B) vs RVP (38.2M).
IARTRVPIART / RVP
Capitalization1.04B29.2M3,558%
EBITDA-332.17M-829.43K40,048%
Gain YTD-41.18241.589-99%
P/E Ratio66.48N/A-
Revenue1.62B38.2M4,246%
Total Cash254M33.1M767%
Total Debt2.01B1.07M188,754%
FUNDAMENTALS RATINGS
IART vs RVP: Fundamental Ratings
IART
RVP
OUTLOOK RATING
1..100
2350
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9795
PRICE GROWTH RATING
1..100
6440
P/E GROWTH RATING
1..100
74
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RVP's Valuation (50) in the Medical Specialties industry is in the same range as IART (80). This means that RVP’s stock grew similarly to IART’s over the last 12 months.

RVP's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as IART (100). This means that RVP’s stock grew similarly to IART’s over the last 12 months.

RVP's SMR Rating (95) in the Medical Specialties industry is in the same range as IART (97). This means that RVP’s stock grew similarly to IART’s over the last 12 months.

RVP's Price Growth Rating (40) in the Medical Specialties industry is in the same range as IART (64). This means that RVP’s stock grew similarly to IART’s over the last 12 months.

RVP's P/E Growth Rating (4) in the Medical Specialties industry is in the same range as IART (7). This means that RVP’s stock grew similarly to IART’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IARTRVP
RSI
ODDS (%)
Bearish Trend 6 days ago
64%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
72%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
64%
Bullish Trend 4 days ago
69%
MACD
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
72%
Bullish Trend 4 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
75%
Bullish Trend 4 days ago
74%
Advances
ODDS (%)
Bullish Trend 13 days ago
60%
Bullish Trend 7 days ago
71%
Declines
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 20 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
66%
Bearish Trend 4 days ago
85%
Aroon
ODDS (%)
Bearish Trend 4 days ago
64%
Bullish Trend 4 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
IART
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MFRLX51.80N/A
N/A
MFS Research R1
BDFIX36.59N/A
N/A
Baron Discovery Institutional
AVEEX14.87N/A
N/A
Avantis® Emerging Markets Equity Instl
FSEBX14.81N/A
N/A
Fidelity Sustainable U.S. Equity
CRCRX9.41-0.11
-1.16%
NYLI CBRE Real Estate Class C

IART and

Correlation & Price change

A.I.dvisor indicates that over the last year, IART has been loosely correlated with ENOV. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if IART jumps, then ENOV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IART
1D Price
Change %
IART100%
-9.93%
ENOV - IART
59%
Loosely correlated
-5.36%
CNMD - IART
54%
Loosely correlated
-6.01%
ITGR - IART
53%
Loosely correlated
-2.27%
ZBH - IART
52%
Loosely correlated
-2.73%
RVTY - IART
49%
Loosely correlated
-3.68%
More